Home/Filings/4/0001140361-24-005498
4//SEC Filing

Connelly Robert 4

Accession 0001140361-24-005498

CIK 0001601485other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 6:01 AM ET

Size

5.4 KB

Accession

0001140361-24-005498

Insider Transaction Report

Form 4
Period: 2024-02-01
Connelly Robert
DirectorCEO, President and Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-02-01+225,137225,137 total
    Exercise: $4.50Exp: 2034-02-01Common Stock (225,137 underlying)
Footnotes (1)
  • [F1]Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Issuer

Elicio Therapeutics, Inc.

CIK 0001601485

Entity typeother

Related Parties

1
  • filerCIK 0001796436

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:01 AM ET
Size
5.4 KB